Markets:

Overview

News

Currencies

International

Treasuries

Monopar Therapeutics Inc. - Common Stock (NQ:MNPR)

109.96 -2.42 (-2.15%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Monopar Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023 ↗

March 29, 2023

Via Benzinga

Nasdaq Dips 90 Points; Walgreens Posts Upbeat Q2 Results ↗

March 28, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 90 points on Tuesday. The Dow traded down 0.21% to 32,362.74 while the NASDAQ fell 0.77% to 11,678.39. The...

Via Benzinga

5 Analysts Have This to Say About Monopar Therapeutics ↗

March 28, 2023

Via Benzinga

What's Going On With Monopar Therapeutics Shares Today? ↗

February 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 28, 2023

Via Benzinga

Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 28, 2023

Gainers

Via Benzinga

Dow Rises 50 Points; Harmony Biosciences Shares Plunge ↗

March 28, 2023

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 50 points on Tuesday. The Dow traded up 0.16% to 32,484.24 while the NASDAQ fell 0.75% to 11,681.12. The S&P 500, also...

Via Benzinga

Monopar Therapeutics Shelves Development Of Validive For Radiation Therapy-Related Complication ↗

March 28, 2023

Monopar Therapeutics Inc (NASDAQ: MNPR) completed a pre-specified interim analysis for its Validive Phase 2b/3 VOICE trial for the prevention of severe oral mucositis (SOM) in patients undergoing...

Via Benzinga

Monopar Therapeutics Shares Are Tumbling: What's Going On? ↗

March 28, 2023

Monopar Therapeutics Inc (NASDAQ: MNPR) shares are plunging in early trading Tuesday after the company announced it will discontinue the active development of Validive after being informed...

Via Benzinga

Why Is Alibaba (BABA) Stock Up 9% Today? ↗

March 28, 2023

Alibaba (BABA) stock is on the rise Tuesday after the company revealed plans to split up into six businesses and become a holding company.

Via InvestorPlace

Why Is WiSA Technologies (WISA) Stock Down 22% Today? ↗

March 28, 2023

WiSA Technologies (WISA) stock is falling on Tuesday but that's only after the company's shares underwent a rally yesterday.

Via InvestorPlace

Why Is Monopar Therapeutics (MNPR) Stock Down 47% Today? ↗

March 28, 2023

Monopar Therapeutics (MNPR) stock is taking a beating on Tuesday after the company revealed lackluster clinical trial results.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 28, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

March 28, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday!

Via InvestorPlace

Monopar to Present at the Jefferies Radiopharma Innovation Summit

March 28, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

Monopar Announces Result of Interim Analysis of Phase 2b/3 VOICE Trial Evaluating Validive for Severe Oral Mucositis

March 27, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 23, 2023

We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Thursday morning!

Via InvestorPlace

Monopar Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Developments

March 23, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 21, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

March 21, 2023

We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 16, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 16, 2023

It's time for another dive into the biggest pre-market stock movers as we go over all the latest news for Thursday morning!

Via InvestorPlace

Monopar to Present at the 35th Annual Roth Conference

March 07, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 02, 2023

It's time for another dive into the biggest pre-market stock movers as we check out all the latest news for Thursday morning!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 28, 2023

It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Monday!

Via InvestorPlace

Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket ↗

February 27, 2023

Gainers Lucira Health, Inc. (NASDAQ: LHDX) rose 228.5% to $0.46 in pre-market trading after the FDA authorized Lucira's over-the-counter at-home test to detect both influenza and COVID-19 viruses.

Via Benzinga

Monopar and NorthStar Announce Expanded Radiopharma Program, Positive Preclinical Results, and Visibility Toward Human Trials

February 27, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 22, 2023

Via Benzinga

Monopar Announces Camsirubicin Clinical Program Update - Improved Side Effect Profile Seen to Date Compared to Doxorubicin

February 14, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

Monopar Announces Projected Timeline of Upcoming Q1 2023 Data Events for Validive, Camsirubicin, and MNPR-101 RIT

January 26, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.